Cornea · 2001 · 38 citations · 6 references
MedicineDermatologyOphthalmologyOcular DiseaseOcular PharmacologyPhotodermatologyCorneal DegenerationCorneal DiseaseCorneal DisordersCorneal EdemaMedication Effects On VisionTopical Ophthalmic MedicationsCase Report AssessmentClinical Case History AssessmentClinical History AssessmentCorneal ComplicationsDiscoloration PatternsDosage AdditionDrug-induced Ocular Adverse EffectsOcular Drug Toxicity
PURPOSE: To report a case of dermal and ocular changes after prolonged use of high-dose chlorpromazine hydrochloride therapy. METHOD: This case report includes clinical history, clinical findings, and photographic images of ocular and dermal changes. RESULTS. Chlorpromazine therapy in a cumulative dosage exceeding 1,100 g resulted in dramatic skin discoloration and multiple crystalline deposits in both corneas. Anterior capsular opacities were binocularly present. These changes were sufficient to cause reduction in visual acuity. CONCLUSIONS: Chlorpromazine deposition at high levels can cause reduction in visual acuity and significant skin discoloration.
6
Chlorpromazine-induced corneal endothelial phototoxicity.
D. Hull, Stephen Csukas, K Green · PubMed · 1982 · 32 citations
Ocular Changes Occurring With Prolonged
Robert F. Prien · Archives of General Psychiatry · 1970 · 28 citations
Asymmetric anterior segment changes induced by chlorpromazine.
Deluise Vp, Flynn Jt · PubMed · 1981 · 22 citations